Since 2-DG became available in Germany in 2018, The Lampidis Cancer Foundation has been actively collaborating with participating doctors and
We have been developing 2-deoxy-D-glucose (2-DG), an analog of glucose, as a non-toxic anti-cancer agent and in an FDA-approved Phase I clinical trial, found it to be safe in patients. In the trial, 2-DG was
Combining non-toxic glycolytic inhibitors with non-toxic antibiotics Although it has long been known that the anti-oxidant properties of vitamin C
In a recent publication titled 2-Deoxy-D-Glucose Inhibits Aggressive Triple-negative Breast Cancer Cells By Targeting Glycolysis And The Cancer Stem Cell
As reported in September, the Lampidis Cancer Foundation, along with the MCS Foundation for Life, has been actively collaborating with
An article published in the British journal Nature last week reports the anti-cancer activity of the naturally found sugar mannose. Mannose is identical to glucose except for a slight modification on what is known as
Dr. Lampidis Collaborates on Groundbreaking 2-DG Clinical Trial in Germany We are delighted to announce today that the Lampidis Cancer
A group of Students for 2-DG, led by Kimi Lampidis, daughter of renowned cancer researcher Dr. Theodore Lampidis, have recorded
$1 is donated to the Lampidis Cancer Foundation for every prescription filled with this card. Present this card to your pharmacy for
It has long been recognized that the highly complex immune system plays a significant role in protecting the human body